Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego
Book Now
Menu
Book Now
keyboard_arrow_right

Main Conference Day 3 - PT (Pacific Time, GMT-08:00)

keyboard_arrow_leftSearch & Filter
close
Main Conference Day 3 - PT (Pacific Time, GMT-08:00)
close
Showing 1 of 1 Streams
2:15pm - 2:45pm
Expanding the Toolbox: Non-natural Amino Acids Enable Development of a CD30 Dual-payload ADC
  • Megan Rice - Associate Principal Scientist, AstraZeneca
Showing 1 of 1 Streams
4:15pm - 4:45pm
Expanding the Fc Functional Spectrum: A Diverse Repertoire of Novel Fc Variants for Enhanced Potency, Complete Effector Silencing, Extended Persistence, and Accelerated Pathogenic IgG Clearance

Our group has developed a portfolio of novel Fc variants comprising distinct designs for enhanced target-cell clearance, complete silencing of Fc-mediated effector functions, extended serum persistence, and accelerated elimination of pathogenic IgG autoantibodies. Their marked functional gains relative to established Fc variants incorporated into marketed therapeutics will be presented.

  • Sang Taek Jung, PhD - Associate Professor, Seoul National University
Main Conference Day 2
Filter
Streams
Formats
Choose Day